Sleep apnea is a disorder in which breathing repeatedly stops and starts during sleep. The most common form — obstructive sleep apnea (OSA) — occurs when the muscles of the throat relax during sleep, causing the airway to narrow or collapse entirely. The brain registers falling blood oxygen, triggers an arousal response, and the person partially wakes — often without knowing — to resume breathing. This can happen dozens or even hundreds of times per night.
The consequence is not simply snoring. Each apnea event stresses the cardiovascular system, fragments sleep architecture, reduces blood oxygen saturation, activates the sympathetic nervous system, and generates systemic inflammation. Over years, these repeated micro-stresses accumulate into serious health consequences.
Types of Sleep Apnea
Obstructive sleep apnea (OSA) is by far the most common type — accounting for around 84% of cases. The airway physically collapses due to anatomical factors and muscle relaxation during sleep. The respiratory drive continues (the brain is still sending signals to breathe), but airflow is blocked.
Central sleep apnea (CSA) occurs when the brain fails to send proper signals to the breathing muscles. There is no airway obstruction — the breathing attempt simply does not happen. CSA is less common and is associated with heart failure, neurological conditions, and opioid use.
Complex sleep apnea (treatment-emergent central apnea) describes a pattern where OSA is present but central apneas emerge when OSA is treated with CPAP. This is more common than previously recognized and may require adaptive ventilation therapies.
Recognizing the Symptoms
Sleep apnea often goes unrecognized because many of its most obvious symptoms occur during sleep, when the person is unaware of them. A bed partner's observations are frequently what prompt diagnosis.
🌙 Nighttime Symptoms
- Loud, chronic snoring
- Witnessed pauses in breathing
- Gasping or choking sounds
- Frequent nighttime awakenings
- Nocturia (waking to urinate)
- Night sweats
- Teeth grinding (bruxism)
- Restless sleep
☀️ Daytime Symptoms
- Excessive daytime sleepiness
- Morning headaches
- Unrefreshing sleep despite adequate hours
- Difficulty concentrating
- Memory problems
- Irritability and mood changes
- Reduced libido
- Falling asleep during passive activities
While loud snoring is the most recognized symptom, a meaningful minority of people with OSA — particularly women and those with central sleep apnea — do not snore loudly or noticeably. Unexplained daytime sleepiness, unrefreshing sleep, and morning headaches in the absence of snoring are still worth investigating.
Measuring Severity: The AHI
Sleep apnea is diagnosed and graded using the Apnea-Hypopnea Index (AHI) — the average number of apneas (complete breathing pauses of 10 seconds or more) and hypopneas (partial reductions in airflow) per hour of sleep.
| Severity | AHI (events/hour) | Typical Presentation |
|---|---|---|
| Normal | Less than 5 | No significant apnea; occasional breathing irregularities are normal |
| Mild OSA | 5 to 14 | Some sleep disruption; daytime sleepiness may be mild or absent |
| Moderate OSA | 15 to 29 | Meaningful sleep fragmentation; daytime function typically affected |
| Severe OSA | 30 or more | Profound sleep disruption; cardiovascular and metabolic risk significantly elevated |
AHI alone does not capture the full picture. Blood oxygen desaturation (how far oxygen levels drop during events), the duration of events, and the person's symptoms and daytime function all factor into treatment decisions. Someone with an AHI of 8 who has significant daytime sleepiness and cardiovascular risk factors may warrant more aggressive treatment than someone with an AHI of 20 who has no symptoms.
Who Is at Risk
Excess body weight is the most modifiable risk factor for OSA. Fat deposits in the upper airway — particularly around the tongue, soft palate, and lateral pharyngeal walls — narrow the airway and increase its collapsibility during sleep. However, OSA occurs at all body weights, and slim individuals with certain anatomical features (retrognathia, a small jaw, large tonsils) can have severe OSA.
Anatomical factors that increase risk include a narrow airway, enlarged tonsils or adenoids, a small or recessed jaw, a large tongue relative to the airway, and a low-lying soft palate.
Sex: Men are diagnosed with OSA at approximately twice the rate of premenopausal women. After menopause, the sex difference narrows significantly — progesterone appears to have a protective effect on upper airway muscle tone. Women with OSA are more likely to present with insomnia, mood disturbance, and fatigue rather than classic snoring-and-gasping, which contributes to under-diagnosis in this group.
Age: OSA prevalence increases with age, partly due to changes in airway anatomy and upper airway muscle tone.
Alcohol and sedatives: Both relax upper airway musculature, worsening apnea severity. Even moderate alcohol consumption meaningfully increases the AHI in people with existing OSA.
Nasal congestion: Chronic nasal obstruction increases the effort required for nasal breathing, promoting mouth breathing and increasing airway collapse risk during sleep.
The Health Consequences of Untreated OSA
Each apnea event triggers a cascade of physiological stress responses. The brief oxygen desaturation activates the sympathetic nervous system, spiking blood pressure and heart rate. Repeated thousands of times per night, these micro-stresses contribute to chronic cardiovascular pathology.
Cardiovascular disease: OSA is an independent risk factor for hypertension — present in approximately 50% of OSA patients. It is associated with significantly elevated rates of atrial fibrillation, coronary artery disease, heart failure, and stroke. The relationship is bidirectional: heart failure exacerbates central sleep apnea, while sleep apnea accelerates cardiac remodeling.
Metabolic effects: OSA impairs glucose metabolism through multiple mechanisms — sympathetic activation, cortisol dysregulation, sleep fragmentation-induced insulin resistance, and intermittent hypoxia. The association between OSA and type 2 diabetes is strong and partly independent of obesity.
Cognitive function: Even moderate OSA is associated with reduced attention, executive function, memory consolidation, and processing speed. These effects may result from reduced slow-wave sleep (fragmented by arousals), intermittent hypoxia damaging prefrontal cortex circuits, and loss of the overnight glymphatic clearance that requires sustained sleep.
Mental health: Depression and anxiety are significantly more common in people with OSA. The relationship is complex — sleep fragmentation worsens mood, while untreated depression impairs sleep. But treatment of OSA independently improves depressive symptoms in a meaningful proportion of patients.
Diagnosis: Polysomnography and Home Testing
In-laboratory polysomnography (PSG) is the gold standard for diagnosing sleep apnea. It measures EEG (to stage sleep), airflow, respiratory effort, oxygen saturation, heart rate, and body position simultaneously through a full night in a sleep laboratory. It can detect OSA, CSA, and other sleep disorders, and can distinguish between them.
Home sleep apnea testing (HSAT) uses portable devices worn at home to measure airflow, respiratory effort, and oxygen saturation. For patients with a high pre-test probability of moderate-to-severe OSA without significant comorbidities, HSAT has comparable diagnostic accuracy to PSG and is less expensive and more convenient. It cannot stage sleep, however, and may underestimate AHI in patients who move around significantly or have other sleep disorders.
Treatment Options
CPAP (Continuous Positive Airway Pressure) is the most effective treatment for moderate-to-severe OSA. A CPAP machine delivers a constant stream of pressurized air through a mask, acting as a pneumatic splint to keep the airway open throughout the night. When used consistently, it eliminates apneas, normalizes oxygen levels, reduces blood pressure, improves daytime alertness, and mitigates many of the cardiovascular risks associated with OSA.
CPAP's main challenge is adherence — roughly 40 to 50% of patients either do not use it consistently or abandon it. Modern CPAP machines are quieter and more comfortable than their predecessors. Auto-adjusting CPAP (APAP) automatically adjusts pressure to match the minimum required on a breath-by-breath basis, which improves comfort for many patients. Mask fit is critical — a poorly fitting mask causes air leaks, noise, and discomfort, and is one of the most common causes of abandonment.
Mandibular advancement devices (MADs) are custom-fitted oral appliances worn during sleep that hold the lower jaw slightly forward, which physically widens the oropharynx and reduces airway collapsibility. They are generally less effective than CPAP for severe OSA but can be as effective for mild-to-moderate OSA and have significantly better adherence rates in many patients. They work by repositioning anatomy rather than splinting the airway with pressure.
Positional therapy is appropriate for the subset of patients with exclusively positional OSA — where apneas occur primarily when sleeping supine (on the back). Devices that discourage supine sleep (vibrating alarms, body position pillows) can markedly reduce AHI in this group with minimal disruption.
Upper airway surgery — including uvulopalatopharyngoplasty (UPPP) and more recent tongue-base reduction procedures — can be effective for selected patients with specific anatomical obstructions. Success rates are variable and depend heavily on patient selection.
Hypoglossal nerve stimulation (Inspire therapy) is an implanted device approved for moderate-to-severe OSA in patients who cannot tolerate CPAP. It delivers mild electrical stimulation to the hypoglossal nerve during inspiration, moving the tongue forward and opening the airway. Clinical trials have demonstrated significant reductions in AHI and patient-reported outcomes.
Weight loss reduces OSA severity in overweight patients — sometimes dramatically. A 10% reduction in body weight can produce a roughly 26% reduction in AHI. However, weight loss rarely eliminates OSA entirely in moderate-to-severe cases and should not delay CPAP initiation.
The single most important thing to do is seek evaluation. A home sleep test ordered by your clinician is a low-barrier first step for most people with classic risk factors. Untreated moderate-to-severe OSA carries genuine cardiovascular risk that accumulates over years. Treatment — particularly with consistent CPAP use — significantly changes those outcomes.